During the past decade, Ochsner Health Center-Summa conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 57 clinical trials were completed, i.e. on average, 87.7% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 40 clinical trials were completed. i.e. 285.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ochsner Health Center-Summa" #1 sponsor was "National Cancer Institute (NCI)" with 60 trials, followed by "SWOG Cancer Research Network" with 25 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "Eastern Cooperative Oncology Group" with 6 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ochsner Health Center-Summa" #1 collaborator was "National Cancer Institute (NCI)" with 46 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Ochsner Health Center-Summa" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Recurrent Breast Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Recurrent Lung Non-Small Cell Carcinoma" (6 trials) and "Recurrent Melanoma" (6 trials). Many other conditions were trialed in "Ochsner Health Center-Summa" in a lesser frequency.

Most popular intervention types in "Ochsner Health Center-Summa" are "Drug" (84 trials), "Other" (72 trials), "Biological" (51 trials), "Procedure" (22 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (50 trials), "Quality-of-Life Assessment" (29 trials), "Biospecimen Collection" (14 trials), "Nivolumab" (14 trials) and "Questionnaire Administration" (13 trials). Other intervention names were less common.

The vast majority of trials in "Ochsner Health Center-Summa" are 93 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Ochsner Health Center-Summa". undefined are not yet recruiting, 16 are recruiting, 59 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Ochsner Health Center-Summa, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Ochsner Health Center-Summa, 1 "Phase 1" clinical trials were conducted, 46 "Phase 2" clinical trials and 64 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".